- The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids
- Industry moves beyond compliance and reaffirms its commitment to ensuring an ethical framework as a way to increase integrity and trust
- Industry presents new Code to patients and healthcare professionals
GENEVA--(BUSINESS WIRE)--The new Code of Practice of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) came into effect on 1 January 2019. The 2019 Code is marked by two important changes. First, it bans gifts and promotional aids (so-called “goodies”) for prescription medicines, wherever IFPMA member companies operate. Second, it introduces a shift from a rules-based approach to a values-based Code, which seeks to help better guide business behaviors and interactions between IFPMA members and the healthcare community.
Morgane De Pol
Manager, Communications and Public Affairs
+ 41 22 38 32 00 / +41 79 962 11 95